Mahickra Chemicals Ltd
Mahickra Chemicals Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Mahickra Chemicals Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
EBITDA for the quarter: Rs.
From Mahickra Chemicals Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.
Revenue & Sales Performance
See what Mahickra Chemicals Ltd said on revenue & sales performance — free account, 30 seconds.
Profitability & Margins
See what Mahickra Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Original capital expenditure allocation of Rs.
- As of 30th September 2026, Rs. 434.74 lakhs of the issue proceeds are invested in Fixed Deposit; Rs. 624.35 lakhs remain unutilized.
- Utilization till 30th September 2025 was consistent with original prospectus objects, including some capex spend, but the later reallocation changed the use of funds.
- The auditor certifies the preferential issue proceeds utilization is compliant with revised objects.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mahickra Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Mahickra Chemicals Ltd said on order book & pipeline — free account, 30 seconds.
Continue your research
Others in Chemicals & Petrochemicals this season
- Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
- Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
- Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care
- Poddar Pigments Ltd (Q2 FY27)
450.67 lakh (~4.9%). Key results statement takeaways from Poddar Pigments Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mahickra Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mahickra Chemicals Ltd Q2 FY27 results?
EBITDA for the quarter: Rs.
What is Mahickra Chemicals Ltd share price analysis?
Mahickra Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 58.4 with a market cap of ₹301 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mahickra Chemicals Ltd planning capital expenditure?
Original capital expenditure allocation of Rs.
Keep Mahickra Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.